Should You Think About Buying Tri Chemical Laboratories Inc. (TSE:4369) Now?
Tri Chemical Laboratories Inc. (TSE:4369), is not the largest company out there, but it received a lot of attention from a substantial price movement on the TSE over the last few months, increasing to JP¥4,180 at one point, and dropping to the lows of JP¥2,868. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Tri Chemical Laboratories' current trading price of JP¥2,868 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Tri Chemical Laboratories’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.
What's The Opportunity In Tri Chemical Laboratories?
According to our valuation model, Tri Chemical Laboratories seems to be fairly priced at around 19.20% above our intrinsic value, which means if you buy Tri Chemical Laboratories today, you’d be paying a relatively reasonable price for it. And if you believe the company’s true value is ¥2405.99, there’s only an insignificant downside when the price falls to its real value. Is there another opportunity to buy low in the future? Since Tri Chemical Laboratories’s share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.
See our latest analysis for Tri Chemical Laboratories
What does the future of Tri Chemical Laboratories look like?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 25% over the next couple of years, the future seems bright for Tri Chemical Laboratories. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.
What This Means For You
Are you a shareholder? It seems like the market has already priced in 4369’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?
Are you a potential investor? If you’ve been keeping an eye on 4369, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth diving deeper into other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.
If you'd like to know more about Tri Chemical Laboratories as a business, it's important to be aware of any risks it's facing. For example - Tri Chemical Laboratories has 2 warning signs we think you should be aware of.
If you are no longer interested in Tri Chemical Laboratories, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.